{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:46:19Z","timestamp":1759495579203},"reference-count":72,"publisher":"Elsevier","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/bs.mie.2019.05.044","type":"book-chapter","created":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T21:34:35Z","timestamp":1560807275000},"page":"257-267","source":"Crossref","is-referenced-by-count":3,"title":["Enzyme activity of circulating CD73 in human serum"],"prefix":"10.1016","author":[{"given":"Silvana","family":"Morello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Turiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Madonna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo A.","family":"Ascierto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariaelena","family":"Capone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/bs.mie.2019.05.044_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fphar.2018.00153","article-title":"Unveiling the role of ecto-5\u2032-nucleotidase\/CD73 in astrocyte migration by using pharmacological tools","volume":"9","author":"Adzic","year":"2018","journal-title":"Frontiers in Pharmacology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1083\/jcb.136.2.421","article-title":"Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells","volume":"136","author":"Airas","year":"1997","journal-title":"The Journal of Cell Biology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0020","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3390\/biom5020775","article-title":"Extracellular adenosine generation in the regulation of pro-inflammatory responses and pathogen colonization","volume":"5","author":"Alam","year":"2015","journal-title":"Biomolecules"},{"key":"10.1016\/bs.mie.2019.05.044_bb0025","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1182\/blood-2010-11-321646","article-title":"Different role of CD73 in leukocyte trafficking via blood and lymph vessels","volume":"21","author":"\u00c5lgars","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/bs.mie.2019.05.044_bb0030","first-page":"145","article-title":"CD73\u2013adenosine: A next-generation target in immuno-oncology","volume":"8","author":"Allard","year":"2016","journal-title":"Future Medicine"},{"key":"10.1016\/bs.mie.2019.05.044_bb0035","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1158\/1078-0432.CCR-13-0545","article-title":"Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs","volume":"19","author":"Allard","year":"2013","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/bs.mie.2019.05.044_bb0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/bs.mie.2019.05.044_bb0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.trecan.2016.01.003","article-title":"Anti-CD73 in cancer immunotherapy: Awakening new opportunities","volume":"2","author":"Antonioli","year":"2016","journal-title":"Trends in Cancer"},{"key":"10.1016\/bs.mie.2019.05.044_bb0050","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1172\/JCI89455","article-title":"Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy","volume":"127","author":"Beavis","year":"2017","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.mie.2019.05.044_bb0055","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/2326-6066.CIR-14-0211","article-title":"Adenosine receptor 2A blockade increases the efficacy of anti-PD-1 through enhanced antitumor T-cell responses","volume":"3","author":"Beavis","year":"2015","journal-title":"Cancer Immunology Research"},{"key":"10.1016\/bs.mie.2019.05.044_bb0060","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1046675","article-title":"CD73: A potential biomarker for anti-PD-1 therapy","volume":"4","author":"Beavis","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0065","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.it.2012.02.009","article-title":"CD73: A potent suppressor of antitumor immune responses","volume":"33","author":"Beavis","year":"2012","journal-title":"Trends in Immunology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0070","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S2213-2600(13)70259-5","article-title":"The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: An open-label study","volume":"2","author":"Bellingan","year":"2014","journal-title":"The Lancet Respiratory Medicine"},{"key":"10.1016\/bs.mie.2019.05.044_bb0075","first-page":"2602","article-title":"The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine","volume":"57","author":"Blay","year":"1997","journal-title":"Cancer Research"},{"key":"10.1016\/bs.mie.2019.05.044_bb0080","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/CIRCRESAHA.113.300180","article-title":"Ecto-5\u2032-nucleotidase on immune cells protects from adverse cardiac remodeling","volume":"113","author":"Bonner","year":"2013","journal-title":"Circulation Research"},{"key":"10.1016\/bs.mie.2019.05.044_bb0085","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bcp.2016.05.006","article-title":"Adenosine signalling mediates the anti-inflammatory effects of the COX-2 inhibitor nimesulide","volume":"112","author":"Caiazzo","year":"2016","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140996","article-title":"Ecto-5\u2032-nucleotidase overexpression reduces tumor growth in a xenograph medulloblastoma model","volume":"10","author":"Cappellari","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.mie.2019.05.044_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/0e219081-9218-480c-aa54-1142a68aed14","article-title":"Characterization of ectonucleotidases in human medulloblastoma cell lines: Ecto-5\u2032NT\/CD73 in metastasis as potential prognostic factor","volume":"7","author":"Cappellari","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/bs.mie.2019.05.044_bb0100","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1084\/jem.20130249","article-title":"Extracellular adenosine regulates naive T cell development and peripheral maintenance","volume":"210","author":"Cekic","year":"2013","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/bs.mie.2019.05.044_bb9000","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4049\/jimmunol.1101845","article-title":"Adenosine A2B receptor blockade slows growth of bladder and breast tumor","volume":"188","author":"Cekic","year":"2012","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0105","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4049\/jimmunol.1003884","article-title":"Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production","volume":"187","author":"Clayton","year":"2011","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0110","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.RES.65.3.531","article-title":"Metabolism of adenine nucleotides in human blood","volume":"65","author":"Coade","year":"1989","journal-title":"Circulation Research"},{"key":"10.1016\/bs.mie.2019.05.044_bb0115","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalysed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/bs.mie.2019.05.044_bb0120","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00432-017-2567-3","article-title":"Ecto-5\u2032-nucleotidase\/CD73 contributes to the radiosensitivity of T24 human bladder cancer cell line","volume":"144","author":"Dietrich","year":"2018","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0125","first-page":"103","article-title":"Increased 5\u2032nucleotidase activity in the blood serum of brain tumor patients","volume":"28","author":"Engroff","year":"2016","journal-title":"Vittalle\u2014Revista de Ci\u00eancias da Sa\u00fade"},{"key":"10.1016\/bs.mie.2019.05.044_bb0130","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.4049\/jimmunol.1200744","article-title":"Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma","volume":"189","author":"Forte","year":"2012","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0135","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11302-018-9642-3","article-title":"Hydrolysis of ATP, ADP, and AMP is increased in blood plasma of prostate cancer patients","volume":"15","author":"Gardani","year":"2019","journal-title":"Purinergic Signalling"},{"key":"10.1016\/bs.mie.2019.05.044_bb0140","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1080\/19420862.2016.1143182","article-title":"Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action","volume":"8","author":"Geoghegan","year":"2016","journal-title":"MAbs"},{"key":"10.1016\/bs.mie.2019.05.044_bb0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.it.2003.11.003","article-title":"Adenosine: An endogenous regulator of innate immunity","volume":"25","author":"Hasko","year":"2004","journal-title":"Trends in Immunology"},{"key":"10.1016\/bs.mie.2019.05.044_bb9005","series-title":"Proceedings of the 106th Annual Meeting of the American Association for Cancer Research; 2015 Apr 18\u201322","article-title":"MEDI9447: enhancing anti-tumor immunity by targeting CD73 In the tumor microenvironment. [abstract]","volume":"vol. 75","author":"Hay","year":"2015"},{"key":"10.1016\/bs.mie.2019.05.044_bb0150","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood.V90.4.1600","article-title":"Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion","volume":"90","author":"Huang","year":"1997","journal-title":"Blood"},{"key":"10.1016\/bs.mie.2019.05.044_bb0155","article-title":"Levels and enzyme activity of CD73 in primary samples from cancer patients","volume":"vol. 75","author":"Huang","year":"2015"},{"key":"10.1016\/bs.mie.2019.05.044_bb0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2005.01.003","article-title":"The 5\u2032-nucleotidases as regulators of nucleotide and drug metabolism","volume":"107","author":"Hunsucker","year":"2005","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.mie.2019.05.044_bb0165","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1593\/neo.131748","article-title":"Blockade of A2b adenosine receptor reduces tumor growth and immune suppression mediated by myeloid-derived suppressor cells in a mouse model of melanoma","volume":"15","author":"Iannone","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/bs.mie.2019.05.044_bb0170","first-page":"172","article-title":"Adenosine limits the therapeutic effectiveness of anti-CTLA4 mAb in a mouse melanoma model","volume":"4","author":"Iannone","year":"2014","journal-title":"American Journal of Cancer Research"},{"key":"10.1016\/bs.mie.2019.05.044_bb9020","doi-asserted-by":"crossref","DOI":"10.1038\/nature13085","article-title":"Nucleotide signalling during inflammation","volume":"509","author":"Idzko","year":"2014","journal-title":"Nature"},{"key":"10.1016\/bs.mie.2019.05.044_bb0175","series-title":"European Patent No. WO 2004\/084933, 2004","author":"Jalkanen","year":"2004"},{"key":"10.1016\/bs.mie.2019.05.044_bb9040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12885-018-4073-7","article-title":"Comprehensive evaluation of NT5E\/CD73 expression and its prognostic significance in distinct types of cancers","volume":"18","author":"Jiang","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/bs.mie.2019.05.044_bb0180","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/rheumatology\/38.5.391","article-title":"5\u2032-Nucleotidase as a marker of both general and local inflammation in rheumatoid arthritis patients","volume":"38","author":"Johnson","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/bs.mie.2019.05.044_bb0185","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1002\/eji.200737793","article-title":"IFN-beta protects from vascular leakage via up-regulation of CD73","volume":"37","author":"Kiss","year":"2007","journal-title":"European Journal of Immunology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0190","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11302-012-9349-9","article-title":"Adenosine as an endogenous immunoregulator in cancer pathogenesis: Where to go?","volume":"9","author":"Kumar","year":"2013","journal-title":"Purinergic Signalling"},{"key":"10.1016\/bs.mie.2019.05.044_bb0195","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1017\/S0022215100108436","article-title":"Serum enzymes in head and neck cancer. IV: 5-Nucleotidase","volume":"103","author":"Lal","year":"1989","journal-title":"The Journal of Laryngology and Otology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0200","doi-asserted-by":"crossref","first-page":"11091","DOI":"10.1073\/pnas.1222251110","article-title":"CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer","volume":"110","author":"Loi","year":"2013","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mie.2019.05.044_bb0205","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/IAI.02536-14","article-title":"CD73-generated adenosine is critical for immune regulation during Toxoplasma gondii infection","volume":"83","author":"Mahamed","year":"2015","journal-title":"Infection and Immunity"},{"key":"10.1016\/bs.mie.2019.05.044_bb0210","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1097\/CCM.0000000000000550","article-title":"Early prediction of persistent organ failure by soluble CD73 in patients with acute pancreatitis","volume":"42","author":"Maksimow","year":"2014","journal-title":"Critical Care Medicine"},{"key":"10.1016\/bs.mie.2019.05.044_bb0215","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12967-017-1348-8","article-title":"Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab","volume":"15","author":"Morello","year":"2017","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.mie.2019.05.044_bb0220","doi-asserted-by":"crossref","DOI":"10.4161\/onci.27989","article-title":"Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells","volume":"3","author":"Morello","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0225","article-title":"Myeloid cells in the tumor microenvironment: Role of adenosine","volume":"5","author":"Morello","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0230","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.4049\/jimmunol.165.9.5262","article-title":"Regulation of endothelial CD73 by adenosine: Paracrine pathway for enhanced endothelial barrier function","volume":"165","author":"Narravula","year":"2000","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0235","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.cellbi.2006.03.001","article-title":"Up-regulation of ectonucleotidase activity after cortical stab injury in rats","volume":"30","author":"Nedeljkovic","year":"2006","journal-title":"Cell Biology International"},{"key":"10.1016\/bs.mie.2019.05.044_bb0240","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1002\/eji.200838437","article-title":"IFN-b regulates CD73 and adenosine expression at the blood\u2013brain barrier","volume":"38","author":"Niemela","year":"2008","journal-title":"European Journal of Immunology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0245","doi-asserted-by":"crossref","first-page":"13132","DOI":"10.1073\/pnas.0605251103","article-title":"A2A adenosine receptor protects tumors from antitumor T cells","volume":"103","author":"Ohta","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mie.2019.05.044_bb0250","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"10.1016\/bs.mie.2019.05.044_bb0255","doi-asserted-by":"crossref","first-page":"27315","DOI":"10.1074\/jbc.M113.484212","article-title":"Soluble ecto-5\u2032-nucleotidase(5\u2032-NT), alkaline phosphatase, and adenosine deaminase (ADA1) activities in neonatal blood favor elevated extracellular adenosine","volume":"288","author":"Pettengill","year":"2013","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.mie.2019.05.044_bb0260","first-page":"4697","article-title":"MAPK signaling and inflammation link melanoma phenotype switching to induction of CD73 during immunotherapy","volume":"77","author":"Reinhardt","year":"2017","journal-title":"AACR Journal"},{"key":"10.1016\/bs.mie.2019.05.044_bb0265","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0163-7258(00)00053-X","article-title":"Tumor-promoting functions of adenosine","volume":"87","author":"Spychala","year":"2000","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.mie.2019.05.044_bb0270","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1158\/0008-5472.CAN-12-0420","article-title":"CD73-deficient mice are resistant to carcinogenesis","volume":"72","author":"Stagg","year":"2012","journal-title":"Cancer Research"},{"key":"10.1016\/bs.mie.2019.05.044_bb0275","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1073\/pnas.0908801107","article-title":"Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis","volume":"107","author":"Stagg","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.mie.2019.05.044_bb0280","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11302-006-9000-8","article-title":"Ecto-5\u2032-nucleotidase: Structure function relationships","volume":"2","author":"Strater","year":"2006","journal-title":"Purinergic Signalling"},{"key":"10.1016\/bs.mie.2019.05.044_bb0285","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1172\/JCI0215337","article-title":"Ecto-5\u2032-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia","volume":"110","author":"Synnestvedt","year":"2002","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/bs.mie.2019.05.044_bb0290","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11010-006-9148-0","article-title":"Activity and expression of ecto-5\u2032-nucleotidase\/CD73 are increased by thyroid hormones in vascular smooth muscle cells","volume":"289","author":"Tamajusuku","year":"2006","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1016\/bs.mie.2019.05.044_bb0295","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc.2017.86","article-title":"Targeting immunosuppressive adenosine in cancer","volume":"17","author":"Vijayan","year":"2017","journal-title":"Nature Reviews. Cancer"},{"key":"10.1016\/bs.mie.2019.05.044_bb0300","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00262-011-1155-7","article-title":"Enhancement of tumor immunotherapy by deletion of the A 2A adenosine receptor","volume":"61","author":"Waickman","year":"2012","journal-title":"Cancer Immunology, Immunotherapy"},{"key":"10.1016\/bs.mie.2019.05.044_bb0305","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00432-007-0292-z","article-title":"Ecto-5\u2032-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells","volume":"134","author":"Wang","year":"2008","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0310","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","article-title":"Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade","volume":"1783","author":"Yegutkin","year":"2008","journal-title":"Biochimica et Biophysica Acta (BBA)\u2014Molecular Cell Research"},{"key":"10.1016\/bs.mie.2019.05.044_bb0315","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/10409238.2014.953627","article-title":"Enzymes involved in metabolism of extracellular nucleotides and nucleosides: Functional implications and measurement of activities","volume":"49","author":"Yegutkin","year":"2014","journal-title":"Critical Reviews in Biochemistry and Molecular Biology"},{"key":"10.1016\/bs.mie.2019.05.044_bb0320","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1096\/fj.02-1136fje","article-title":"Soluble purine-converting enzymes circulate in human blood and regulate extracellular ATP level via counteracting pyrophosphatase and phosphotransfer reactions","volume":"17","author":"Yegutkin","year":"2003","journal-title":"FASEB Journal"},{"key":"10.1016\/bs.mie.2019.05.044_bb0325","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ccell.2016.06.025","article-title":"Co-inhibition of CD73 and A2AR adenosine signaling improves anti-tumor immune responses","volume":"30","author":"Young","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/bs.mie.2019.05.044_bb0330","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10585-007-9081-y","article-title":"RNA interference of ecto-5\u2032-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion","volume":"24","author":"Zhi","year":"2007","journal-title":"Clinical & Experimental Metastasis"},{"key":"10.1016\/bs.mie.2019.05.044_bb0335","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/bj2850345","article-title":"5\u2032-Nucleotidase: Molecular structure and functional aspects","volume":"285","author":"Zimmermann","year":"1992","journal-title":"Biochemical Journal"},{"key":"10.1016\/bs.mie.2019.05.044_bb0340","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/bs.mie.2019.05.044_bb0345","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuron.2008.08.024","article-title":"Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine","volume":"60","author":"Zylka","year":"2008","journal-title":"Neuron"}],"container-title":["Methods in Enzymology","Tumor Immunology and Immunotherapy \u2013 Molecular Methods"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0076687919302253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0076687919302253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T17:30:15Z","timestamp":1573493415000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0076687919302253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":72,"URL":"https:\/\/doi.org\/10.1016\/bs.mie.2019.05.044","relation":{},"ISSN":["0076-6879"],"issn-type":[{"value":"0076-6879","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}